Literature DB >> 9635855

The multifaceted roles of nitric oxide in cancer.

D A Wink1, Y Vodovotz, J Laval, F Laval, M W Dewhirst, J B Mitchell.   

Abstract

The roles of nitric oxide (NO) in numerous disease states have generated considerable discussion over the past several years. NO has been labeled as the causative agent in different pathophysiological mechanisms, yet appears to protect against various chemical species such as those generated under oxidative stress. Similarly, NO appears to exert a dichotomy of effects within the multistage model of cancer. Chronic inflammation can lead to the production of chemical intermediates, among them NO, which in turn can mediate damage to DNA. Yet, NO also appears to be critical for the tumoricidal activity of the immune system. Furthermore, NO can also have a multitude of effects on other aspects of tumor biology, including angiogenesis and metastasis. This report will discuss how the chemistry of NO may impact the initiation and progression stages of cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635855     DOI: 10.1093/carcin/19.5.711

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  141 in total

1.  Novel repair activities of AlkA (3-methyladenine DNA glycosylase II) and endonuclease VIII for xanthine and oxanine, guanine lesions induced by nitric oxide and nitrous acid.

Authors:  Hiroaki Terato; Aya Masaoka; Kenjiro Asagoshi; Akiko Honsho; Yoshihiko Ohyama; Toshinori Suzuki; Masaki Yamada; Keisuke Makino; Kazuo Yamamoto; Hiroshi Ide
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

Review 2.  Tumor-associated macrophages in breast cancer.

Authors:  Russell D Leek; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 3.  Nitric oxide and cancer therapy: the emperor has NO clothes.

Authors:  Jason R Hickok; Douglas D Thomas
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

4.  Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO.

Authors:  Steven Hutchens; Yefim Manevich; Lin He; Kenneth D Tew; Danyelle M Townsend
Journal:  Invest New Drugs       Date:  2010-03-16       Impact factor: 3.850

5.  Photoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors.

Authors:  Michael J Rose; Pradip K Mascharak
Journal:  Coord Chem Rev       Date:  2008-10-01       Impact factor: 22.315

6.  The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.

Authors:  Keiji Tanese; Elizabeth A Grimm; Suhendan Ekmekcioglu
Journal:  Int J Cancer       Date:  2011-10-23       Impact factor: 7.396

7.  Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.

Authors:  Martha L Slattery; Abbie Lundgreen; Bill Welbourn; Roger K Wolff; Christopher Corcoran
Journal:  Mutat Res       Date:  2012-04-15       Impact factor: 2.433

Review 8.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

9.  Evaluation of the effects of nicorandil and its molecular precursor (without radical NO) on proliferation and apoptosis of 786-cell.

Authors:  Natália Aparecida de Paula; Andressa Megumi Niwa; Diogo Campos Vesenick; Carolina Panis; Rubens Cecchini; Angelo de Fátima; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Cytotechnology       Date:  2013-01-17       Impact factor: 2.058

10.  Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma.

Authors:  Wei Li; Ru-jun Xu; Li-hui Jiang; Jingfeng Shi; Xiang Long; Bei Fan
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.